This case is a story with no drama. No sudden crisis. No last-minute rescues. It’s about a clinical trial that ran perfectly from start to finish. And that in itself is a story worth telling. The sponsor needed to test a new nonsteroidal anti-inflammatory drug (NSAID). They had worked with Premier Research before, and knew our track record in analgesia studies: More than 870 pain trials treating over 110,000 patients, including trials for all of the NSAID analgesics on the market today.